Literature DB >> 1819684

Kinetic studies of human and rat neutrophil lysoPAF acetyltransferase using lysoPAF and dansyllysoPAF as substrates.

P W Schindler1, E Ninio.   

Abstract

Enzyme kinetic studies of lysoPAF acetyltransferase from microsomal preparations of human and rat neutrophils were carried out using lysoPAF or dansyllysoPAF as substrate. With the human enzyme, incomplete conversion of the substrate into the product was observed at 37 degrees C with both substrates. The acetyltransferase was inactivated at 37 degrees C in the absence of substrate with a half-life of 7.5 min. However, the initial rate of product formation under the assay conditions was linear up to 10 min. Both enzymes were optimally active at 40 microM concentration with either substrate, but enzyme activity was inhibited at higher substrate levels. At a constant substrate concentration (40 microM), the Km (microM) and Vmax (nmol product/min/mg protein) values for the human acetyltransferase, with respect to acetyl-CoA were 132 and 23.1, respectively, with lysoPAF as substrate, and 105 and 26.7, respectively, when dansyllysoPAF was used. The Km and Vmax values for the rat enzyme were 105 and 6.5, respectively, with lysoPAF as substrate, and 120 and 5.4, respectively, when dansyllysoPAF was used. Under our standard conditions, lysoPAF required 1 mg of BSA per mL in the assay, whereas full activity of both enzymes was seen with dansyllysoPAF even in the absence of BSA. The results show that dansyllysoPAF can replace lysoPAF in the assay without any significant changes in kinetic parameters.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819684     DOI: 10.1007/BF02536492

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  19 in total

Review 1.  Platelet activating factor and asthma.

Authors:  J Morley
Journal:  Agents Actions       Date:  1986-10

Review 2.  Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids.

Authors:  F Snyder
Journal:  Med Res Rev       Date:  1985 Jan-Mar       Impact factor: 12.944

3.  Migration of peritoneal polymorphonuclear leucocytes in the rat.

Authors:  F M Cunningham; M J Smith; A W Ford-Hutchinson; J R Walker
Journal:  J Pathol       Date:  1979-05       Impact factor: 7.996

4.  Biosynthesis of platelet activating factor. Substrate specificity of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase in rat spleen microsomes.

Authors:  T C Lee
Journal:  J Biol Chem       Date:  1985-09-15       Impact factor: 5.157

5.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

Authors:  T W Doebber; M S Wu; J C Robbins; B M Choy; M N Chang; T Y Shen
Journal:  Biochem Biophys Res Commun       Date:  1985-03-29       Impact factor: 3.575

6.  Calmodulin antagonists inhibit formation of platelet-activating factor in stimulated human neutrophils.

Authors:  M M Billah; M I Siegel
Journal:  Biochem Biophys Res Commun       Date:  1984-01-30       Impact factor: 3.575

7.  Regulation of platelet activating factor synthesis: modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomes.

Authors:  D J Lenihan; T C Lee
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

8.  Modulation of lyso-platelet activating factor: acetyl-CoA acetyltransferase from rat splenic microsomes. The role of cyclic AMP-dependent protein kinase.

Authors:  J Gómez-Cambronero; S Velasco; J M Mato; M Sánchez-Crespo
Journal:  Biochim Biophys Acta       Date:  1985-06-30

9.  Biosynthesis of platelet-activating factor (PAF-acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187.

Authors:  E Ninio; J M Mencia-Huerta; J Benveniste
Journal:  Biochim Biophys Acta       Date:  1983-05-16

10.  The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall.

Authors:  R H Bourgain; L Maes; P Braquet; R Andries; L Touqui; M Braquet
Journal:  Prostaglandins       Date:  1985-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.